Detalles de la búsqueda
1.
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.
BMC Cancer
; 14: 954, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25512030
2.
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.
Front Immunol
; 15: 1336566, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38510242
3.
Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 115(3): 608-621, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36202181
4.
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Breast Cancer Res
; 13(6): R117, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22112244
5.
Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer.
Front Immunol
; 8: 1476, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29163540
6.
Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy.
Cancer Immunol Res
; 4(5): 431-40, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27009165
Resultados
1 -
6
de 6
1
Próxima >
>>